Dental Soft-Tissue Regeneration Companies

The dental soft-tissue regeneration market is projected to reach USD 0.53 billion by 2030 from USD 0.38 billion in 2025, at a CAGR of 6.8% from 2025 to 2030. Dental soft-tissue regeneration involves restoring or replacing biological or synthetic soft structures or tissues lost in the oral cavity, particularly the gums and connective tissues. This procedure utilizes biological materials, growth factors, and cellular technologies to promote tissue repair and reconstruction and enhance oral health. Dental soft-tissue regeneration is beneficial for managing periodontitis, correcting gingival recession, and placing dental implants, ultimately improving both aesthetic and functional outcomes.

Some of the prominent players operating in the market include Geistlich Pharma AG (Switzerland), DENTSPLY Sirona (US), Institut Straumann AG (Switzerland), ZimVie Inc. (US), Henry Schein, Inc. (US), AbbVie Inc. (US), Advanced Medical Solutions Group Plc (UK), Tissue Regenix (UK), Septodont Holding (France), Medical Consult Implants GmbH (Germany), Meccellis (US), Regedent AG (Switzerland), Regenity (US), Envista (US), AD Surgical (US), LifeNet Health (US), B. & B. Dental S.R.L. (Italy), Alpha-Bio Tec. Ltd. (Israel), Lasak S.R.O. (Czech Republic), KeystoneDentalGroup (US), Neoss AG (Switzerland), BEGO GmbH Co. KG (Germany), Biotech Dental (France), Samyang Holdings Corporation (South Korea), and RTI Surgical (US).

To know about the assumptions considered for the study download the pdf brochure

Geistlich Pharma AG (SWITZERLAND)

Geistlich Pharma AG, based in Switzerland, is a leading company in the field of dental soft-tissue regeneration. It provides a range of biomaterials designed for the regeneration of soft and bone tissue, including collagen membranes, matrices, and bone substitutes. These products are widely used in periodontal treatment, implantology, and oral surgery. Geistlich Pharma markets its products in over 60 countries and actively participates in key global events, such as those focused on osseointegration. The company is also committed to research & development to deliver innovative solutions for its customers and maintain a competitive edge in the market.

INSTITUT STRAUMANN AG (SWITZERLAND)

Institut Straumann AG is a global leader in dental implantology, oral tissue regeneration, and restorative dentistry. The company has actively engaged in the dental soft-tissue regeneration market, offering a wide range of innovative solutions. These include regenerative products designed to enhance tissue regeneration and promote healing for patients with periodontal disease. Straumann's portfolio features biomaterials such as tissue grafts and collagen-based membranes, which are essential for restoring lost bone and tissues. The company is focused on various growth strategies to maintain its leading position in the dental soft-tissue regeneration market.

HENRY SCHEIN, INC. (US)

Henry Schein is an American company recognized as one of the Fortune World's Most Admired Companies. It is the largest distributor of healthcare products and services globally, operating in 32 countries. The company supplies a wide range of healthcare and technology products and value-added services to office-based healthcare professionals.

With its extensive global distribution network, Henry Schein efficiently serves healthcare facilities worldwide, providing various regenerative materials. The company strongly emphasizes acquisitions, innovative product development, and market penetration to maintain its leadership position in the dental soft-tissue regeneration market.

Market Ranking:

A market share analysis, conducted after comprehensive secondary research and validated by feedback from primary respondents, has established the ranking of companies in the global dental soft-tissue regeneration market. This ranking considers various factors, including revenue generated from dental anesthetics, the breadth and depth of the product portfolio, innovation, approvals, and product launches.

According to this analysis, the leading three players in the market are Geistlich Pharma AG (Switzerland), Institut Straumann AG (Switzerland), and Henry Schein, Inc. (US). These companies dominate the market due to their strong presence, extensive product offerings, and strategic acquisitions within the global dental soft-tissue regeneration sector.

Related Reports:

Dental Soft-tissue Regeneration Market by Product Type (Autografts, Synthetic Biomaterials, Collagen-based Membranes), Application (Implantology, Periodontology), End User (Dental Hospitals, DSO's & Independent Clinics), Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com